1. MARKETS
  2. SECTOR : DIVERSIFIED CONSUMER SERVICES
  3. INDUSTRY : HEALTHCARE SERVICES
  4. VANTA BIOSCIENCE LTD.
Vanta Bioscience Ltd.
BSE: 540729
Download real time
Ask AI about Vanta Bioscience
20.420.00(0.00%)
29.59% Fall from 52W High
2,250
BSE Volume

BSE 06 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Vanta Bioscience quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Vanta Bioscience competitor comparison and performance snapshot within industry

Vanta Bioscience annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Annual Revenue Vanta Bioscience Mar-2026 Annual Revenue is Rs 2 Cr which is growth of 69.4% YoY.

  • POSITIVE

    Annual Net Profit Vanta Bioscience Mar-2026 Annual Net Profit is Rs 0 Cr which is growth of 104.5% YoY.

Vanta Bioscience Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17
⌄
-29.9%
-27.7%
21.28.65.89.510.114.212.74
Operating Exp. Ann.
-48%
-33.4%
0.82.84.95.766.19.89.23
Operating Profit Ann.
-
-23.8%
1-1.73.7-0.53.43.94.33.31
OPM Ann. %
-
6.2%
52.17%-141.92%42.44%-8.20%35.74%38.70%30.35%25.83%25.52%-
⌄
-41.5%
-26.8%
23.98.6109.49.512.911.63.7
EBITDA Ann.
81.7%
-21%
1.2-1.63.70.23.63.94.43.51.1
EBITDA Ann. margin %
185.8%
9.1%
60.24%-138.56%42.99%2.58%37.50%38.92%31.12%27.64%26.83%-
Interest Ann.
-36.3%
-17.6%
0.80.72.43.12.12.121.70.2
Depr.
-32.5%
-21%
0.40.41.21.31.31.31.20.70.6
PBT Ann.
-
-
0-2.70-4.20.10.61.31.10.3
Tax Ann.
-
-
-0.1-0.1-000.10.10.30.40.3
⌄
-
-27.5%
0.1-2.70.1-4.20.10.510.70
Net Profit Ann.
-
-27.5%
0.1-2.70.1-4.20.10.510.70
NPM Ann. %
-
7.1%
6.59%-235.88%0.59%-81.90%0.83%4.68%6.92%5.58%0.68%
EPS Adj. latest Ann.
-
-22.2%
0.2-3.70.1-60.10.71.410
Annual Reports
       
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
66.7%
2Y CAGR
-51.8%
3Y CAGR
-29.9%
5Y CAGR
-27.7%
7Y CAGR
-23.2%
Total Revenue Annual growth is higher than historical averages.
Net Profit Ann.
5Y CAGR
-27.5%
7Y CAGR
-24.3%
Net Profit Annual growth is stable compared to historical averages.
Operating Exp. Ann.
1Y CHG
-71.4%
2Y CAGR
-59.6%
3Y CAGR
-48%
5Y CAGR
-33.4%
7Y CAGR
-29.5%
Operating Expenses Annual Cr is falling faster than historical averages.

Vanta Bioscience balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Total Shareholders Fund Vanta Bioscience Mar-2025 Total Shareholders Fund is Rs 21 Cr which is growth of 24.0% YoY.

  • POSITIVE

    Total Assets Vanta Bioscience Mar-2025 Total Assets is Rs 66 Cr which is growth of 18.4% YoY.

Vanta Bioscience Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17
⌄
2.6%
-2.3%
21.317.119.819.72423.923.422.316.66.2
Minority Interest Liability Ann.
-
-
----------
⌄
15.1%
23.5%
33.120.118.921.716.411.51112.610.27.5
⌄
4.6%
1.6%
11.818.614.210.31010.97.13.22.40.1
Total Capital Plus Liabilities Ann.
8.6%
7.4%
66.155.852.951.650.446.341.63829.213.8
⌄
8.7%
10.3%
48.142.437.937.436.129.420.821.619.813
⌄
8.1%
9.3%
51.145.440.940.539.432.724.12420.213.2
⌄
10.6%
2.1%
1510.41211.11113.517.514.190.5
Total Assets Ann.
8.6%
7.4%
66.155.852.951.650.446.341.63829.213.8
Contingent Liabilities plus Commitments Ann.
-
-
-
Bonus Equity Share Capital Ann.
-
-
-
Non Current Investments Unquoted Book Value Ann.
-
-
-3333332
Current Investments Unquoted Book Value Ann.
-
-
-24.5
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Assets Ann.
1Y CHG
18.5%
2Y CAGR
11.8%
3Y CAGR
8.6%
5Y CAGR
7.4%
7Y CAGR
8.2%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
-36.6%
2Y CAGR
-8.8%
3Y CAGR
4.6%
5Y CAGR
1.6%
7Y CAGR
20.5%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
24.6%
2Y CAGR
3.7%
3Y CAGR
2.6%
5Y CAGR
-2.3%
7Y CAGR
-0.7%
Total ShareHolders Funds Annual growth is higher than historical averages.

Vanta Bioscience ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Book Value Per Share Vanta Bioscience Mar-2025 Book Value Per Share is 30 Rs which is growth of 10.1% YoY.

  • POSITIVE

    ROE Vanta Bioscience Mar-2025 ROE is 1% which is growth of 16.1% YoY.

Vanta Bioscience Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17
BVSH Ann.
-1.5%
-4.6%
29.927.131.431.33837.937.135.22916.9
RoA Ann. %
-
-29.2%
0.18%-4.76%0.09%-8.20%0.15%1.01%2.35%1.82%0.09%
ROE Ann. %
-
-22.2%
0.56%-15.52%0.25%-21.45%0.32%1.96%4.17%3.11%0.16%
ROCE Ann. %
-
-27.9%
1.47%-5.51%6.36%-2.65%5.57%7.52%9.39%8.00%1.90%
⌄
          
⌄
          
⌄
          
Total Debt to Total Equity Ann.
11.5%
24.6%
1.81.81.31.30.90.60.50.60.61.2
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
ROE Ann. %
2Y CAGR
49.7%
5Y CAGR
-22.2%
7Y CAGR
-21.7%
ROE Annual % is stable compared to historical averages.
RoA Ann. %
2Y CAGR
41.4%
5Y CAGR
-29.2%
7Y CAGR
-28.1%
RoA Annual % is stable compared to historical averages.
Current Ratio Ann.
1Y CHG
116.7%
2Y CAGR
20.2%
3Y CAGR
5.7%
7Y CAGR
-16%
Current Ratio Annual growth is higher than historical averages.

Vanta Bioscience cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Cash From Operating Activity Vanta Bioscience Mar-2026 Cash From Operating Activity is Rs -5 Cr which is growth of -483.4% YoY.

  • NEUTRAL

    Net Cash Flow Vanta Bioscience Mar-2026 Net Cash Flow is Rs -0 Cr which is growth of 0% YoY.

Vanta Bioscience Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17
⌄
-
-
-5.21.44.50.66.710.93-0.3-6.8-0.3
Cash from Investing Act. Ann.
-
-
-6.9-5.8-1.7-2.5-8.1-9.9-1.4-4.5-7.5-13
Cash from Financing Act. Ann.
85.4%
-
12.14.4-2.81.91.4-1.1-1.8513.913.7
⌄
-
-
-00.10-0-0.20.2-0.40.4
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Cash from Financing Act. Ann.
1Y CHG
175%
3Y CAGR
85.4%
7Y CAGR
13.5%
Cash from Financing Annual Activity growth is stable compared to historical averages.

Vanta Bioscience investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Ask AI
×